MAVENCLAD

emd serono, a division of emd inc., canada🇨🇦 Health Canada

Approval Id: b1cf0d386bf5b7bc
Drug Approval Canada Name: MAVENCLAD
Product Name: MAVENCLAD
Status: Marketed
Status Date: 2017-11-30
Original Market Date: 2017-11-30
Din: 02470179
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 90:04.20
Atc Original: L04AA40* CLADRIBINE
Atc Name: l 04 aa 40*
Aig Number: 0124270002
Company Name: emd serono, a division of emd inc., canada
Company Address: 2695 North Sheridan Way, Suite 200, Mississauga, Ontario, Canada, L5K 2N6

CLADRIBINE

10 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

b1cf0d386bf5b7bc

Type

Standard